NEJM: Modern's vaccine is more effective than Pfizer's

In a new study published yesterday (Wednesday) in the New England Journal of Medicine and reported by the New York Times , a comparison was made “in the real world” between the effectiveness of a company’s vaccine Pfizer compared to that of a modern company. While the two innovative mRNA-based vaccines have been approved for use it has been said that in terms of efficacy they are both equal. But now it turns out from the new study that the data indicate a little differently: there is a difference, even if it is small, in favor of a “modern” vaccine.

Roughly speaking, about 221 million doses of the “Pfizer” vaccine have already been issued For vaccination in the United States, compared to about 150 million of the “Modern” vaccine. About five comparative studies have been published recently, the most recent of which, as stated in “New England”, and the conclusion that emerges from them: Vaccination “Modern” seems to provide greater protection than the Pfizer vaccine months after the injection.

The latest study evaluated efficacy in the “real world” to prevent symptomatic disease among about 5,000 health care professionals And nurses in 25 U.S. states. The effectiveness of the Pfizer vaccine was found to be 88.8%, while that of the Modern is 96.3%. It was also found that the effectiveness of a “modern” vaccine for the prevention of serious illness is in the range of between 92% and 100%, with the Pfizer vaccine lagging behind by about 15% -10%. It was also found that compared to the Delta variant, the “Modern” vaccine is about 30% more effective in prevention.

It was also found that the “Pfizer” vaccine produces one-third to one-half less antibody levels than the one that “Modern” vaccine but the gap is negligible because there are often more than 100 times differences in antibody levels between two healthy people anyway. “Modern” has asked the FDA for approval to give a booster (third dose) at a dose of 50 micrograms – about half the dose of the second dose because the second dose still raises the levels of antibodies in the vaccinated body long after it has been given.

If the gap in efficiency continues to widen, this will also have implications for the debate currently taking place in the US in the context of the booster dose, scientists. Although the difference is not large, it is consistent.

Note: This article has been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
National Police Agency and Incheon City to hold International Public Security Industry Expo in October thumbnail

National Police Agency and Incheon City to hold International Public Security Industry Expo in October

경찰청·인천광역시는 오는 10월20∼22일 인천 송도컨벤시아에서 제3회 국제치안산업박람회를 개최한다고 28일 밝혔다. 이번 박람회는 국내 치안산업 기반 조성과 치안 한류를 통한 선진 치안시스템의 전파를 목적으로 열린다.  전시관은 크게 ▲경찰 기동장비·드론관 ▲경찰 개인장비관 ▲경찰 정보통신(ICT)관 ▲범죄예방 장비·시스템관 ▲범죄수사·감식장비관 ▲교통 장비·시스템관 ▲특별관 등으로 구성될 예정이다. 특별관은 실종자 정밀 위치측정 기술, 실종자 신원확인 기술 등 사회적 약자를 보호하는 첨단 기술을 주제로 전시할 예정이다. 세계 과학수사…
Read More
Pharyngolaryngeal reflux syndrome: a clinical picture [podcast] thumbnail

Pharyngolaryngeal reflux syndrome: a clinical picture [podcast]

Avalie o nosso conteúdo: Houve um erro fazendo sua requisição, por favor tente novamente! Obrigado!Sua avaliação é fundamental para que a gente continue melhorando o Portal Pebmed Quer acessar esse e outros conteúdos na íntegra? Cadastrar GrátisJá tem cadastro? Faça seu login Faça seu login ou cadastre-se gratuitamente para ter acesso ilimitado a todos os…
Read More
Song Young-gil, “Documents for the defense of the mother-in-law, should be held accountable” thumbnail

Song Young-gil, “Documents for the defense of the mother-in-law, should be held accountable”

세계일보 보도 관련 “탄핵소추 사안” 윤석열 전 검찰총장(왼쪽), 장모 최모 씨. 뉴스1, 연합뉴스 국민의힘 윤석열 대선 경선 후보의 검찰총장 재직 시절 대검찰청이 윤 후보 장모인 최모씨의 잔고증명서 위조 사건에 대해 ‘변호 문건’을 생산한 것으로 드러나자 여권에서는 “기가 막힐 일”이라고 윤 후보를 비판했다. 더불어민주당 송영길 대표는 29일 국회에서 열린 최고위원회의에서 “세계일보에서 이번에 윤 후보가 검찰총장 시절에…
Read More
Top 7 cars in India with best safety rating thumbnail

Top 7 cars in India with best safety rating

The Safari has got a 5-star safety rating under the new testing protocol at Global NCAP.Tata SafariThe Harrier has also garnered a 5-star safety rating.Tata HarrierThe Taigun has high safety standards with a 5-star score at Global NCAP.Volkswagen TaigunLike the Taigun, the Virtus has also garnered a 5-star safety rating.Volkswagen VirtusSafety is the prime concern
Read More
Index Of News